HealthEquity Inc. (NASDAQ:HQY) CEO Jon Kessler sold 54,712 shares of the stock in a transaction on Tuesday, September 20th. The stock was sold at an average price of $35.07, for a total value of $1,918,749.84. Following the sale, the chief executive officer now owns 485,288 shares in the company, valued at approximately $17,019,050.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Jon Kessler also recently made the following trade(s):

  • On Monday, September 19th, Jon Kessler sold 65,288 shares of HealthEquity stock. The stock was sold at an average price of $35.02, for a total transaction of $2,286,385.76.
  • On Thursday, September 15th, Jon Kessler sold 20,000 shares of HealthEquity stock. The stock was sold at an average price of $33.46, for a total transaction of $669,200.00.
  • On Monday, September 12th, Jon Kessler sold 120,117 shares of HealthEquity stock. The stock was sold at an average price of $33.10, for a total transaction of $3,975,872.70.
  • On Wednesday, August 31st, Jon Kessler sold 34,883 shares of HealthEquity stock. The stock was sold at an average price of $33.00, for a total transaction of $1,151,139.00.
  • On Monday, July 25th, Jon Kessler sold 10,000 shares of HealthEquity stock. The stock was sold at an average price of $29.62, for a total transaction of $296,200.00.
  • On Friday, July 15th, Jon Kessler sold 10,000 shares of HealthEquity stock. The stock was sold at an average price of $30.05, for a total transaction of $300,500.00.
  • On Thursday, June 23rd, Jon Kessler sold 10,000 shares of HealthEquity stock. The stock was sold at an average price of $29.00, for a total transaction of $290,000.00.

HealthEquity Inc. (NASDAQ:HQY) opened at 36.20 on Thursday. HealthEquity Inc. has a 52 week low of $15.80 and a 52 week high of $36.80. The stock’s 50 day moving average price is $31.56 and its 200-day moving average price is $27.76. The company has a market capitalization of $2.12 billion, a PE ratio of 92.82 and a beta of 1.65.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Tuesday, September 6th. The company reported $0.16 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.13 by $0.03. The business had revenue of $44.20 million for the quarter. HealthEquity had a net margin of 15.21% and a return on equity of 10.89%. The company’s revenue was up 44.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.08 EPS. On average, equities research analysts predict that HealthEquity Inc. will post $0.51 earnings per share for the current fiscal year.

Several research firms have recently weighed in on HQY. Robert W. Baird upped their price target on shares of HealthEquity from $31.00 to $35.00 and gave the stock a “neutral” rating in a report on Wednesday, September 7th. Zacks Investment Research raised shares of HealthEquity from a “hold” rating to a “buy” rating and set a $39.00 price target on the stock in a report on Thursday, September 8th. Wells Fargo & Co. reaffirmed a “buy” rating on shares of HealthEquity in a report on Wednesday, June 8th. SunTrust Banks Inc. reaffirmed a “buy” rating on shares of HealthEquity in a report on Thursday, September 8th. Finally, Barrington Research increased their target price on HealthEquity from $34.00 to $38.00 and gave the company an “outperform” rating in a research note on Thursday, September 8th. Three equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. HealthEquity currently has a consensus rating of “Buy” and a consensus price target of $36.00.

Hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc. boosted its position in shares of HealthEquity by 26.3% in the second quarter. Vanguard Group Inc. now owns 3,150,828 shares of the company’s stock valued at $95,739,000 after buying an additional 656,849 shares in the last quarter. Loomis Sayles & Co. L P acquired a new position in shares of HealthEquity during the second quarter valued at $14,237,000. Norges Bank acquired a new position in shares of HealthEquity during the fourth quarter valued at $10,277,000. Waddell & Reed Financial Inc. boosted its position in shares of HealthEquity by 59.1% in the second quarter. Waddell & Reed Financial Inc. now owns 1,008,110 shares of the company’s stock valued at $30,632,000 after buying an additional 374,529 shares in the last quarter. Finally, Marshall Wace LLP acquired a new position in shares of HealthEquity during the second quarter valued at $6,661,000. Institutional investors and hedge funds own 91.41% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

5 Day Chart for NASDAQ:HQY

Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.